These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 19385584)

  • 1. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
    Austin MS; Abdul-Hadi O; Parvizi J; Viscusi ER; Einhorn T
    Instr Course Lect; 2009; 58():759-68. PubMed ID: 19385584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R; Rubin G; Berenbaum F; Scheiman J
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF; Buchanan WW
    Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [COX-2 Inhibitors for the management of postoperative pain].
    Schug SA
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Jan; 45(1):56-63. PubMed ID: 20091477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When should COX-2 selective NSAIDs be used for osteoarthritis and rheumatoid arthritis?
    Lo V; Meadows SE; Saseen J
    J Fam Pract; 2006 Mar; 55(3):260-2. PubMed ID: 16510063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risks of cyclooxygenase inhibition.
    Stacy ZA; Dobesh PP; Trujillo TC
    Pharmacotherapy; 2006 Jul; 26(7):919-38. PubMed ID: 16803424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitors: what went wrong?
    James MJ; Cleland LG
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):89-94. PubMed ID: 16477171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing?
    Boursinos LA; Karachalios T; Poultsides L; Malizos KN
    J Musculoskelet Neuronal Interact; 2009; 9(1):44-52. PubMed ID: 19240368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs: are they safe after joint arthroplasty for early pain?
    Purtill JJ
    Instr Course Lect; 2007; 56():133-7. PubMed ID: 17472301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of chronic musculoskeletal pain in the elderly: opinions on oral medication use.
    Kean WF; Rainsford KD; Kean IR
    Inflammopharmacology; 2008 Apr; 16(2):53-75. PubMed ID: 18389178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention.
    Scarpignato C; Hunt RH
    Gastroenterol Clin North Am; 2010 Sep; 39(3):433-64. PubMed ID: 20951911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M; Ruschitzka F
    Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
    Lazzaroni M; Battocchia A; Bianchi Porro G
    Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Farkouh ME; Greenberg BP
    Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
    Joshi GP; Gertler R; Fricker R
    Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibitors and cardiovascular risk.
    Solomon SD
    Curr Opin Cardiol; 2006 Nov; 21(6):613-7. PubMed ID: 17053413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
    Dajani EZ; Islam K
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.